Skip to content

The occurrence of auditory and vestibular symptoms in people with fibromyalgia

The incidence of hearing and vestibular changes in people with fibromyalgia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-7hc7ty5
Enrollment
Unknown
Registered
2022-02-18
Start date
2021-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

Group of people who participated in the survey: 541 people. 534 women and 7 men, both genders who claimed to have fibromyalgia. The answers were collected through an online form, in a period of 7 days
C09.218.458.34
C09.218.458.670
C09.218.568.900.883

Sponsors

Débora Pereira Fernandes
Lead Sponsor
Escola de Enfermagem da Universidade de São Paulo
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: People with a medical diagnosis of Fibromyalgia. Over 18 years of age. Residents of the Federative Republic of Brazil

Exclusion criteria

Exclusion criteria: People who denied having a medical diagnosis of fibromyalgia. People who denied having any type of auditory or vestibular symptoms. People without internet access and interest to answer the question form

Design outcomes

Primary

MeasureTime frame
People with fibromyalgia have a high incidence of complaints related to hearing and vestibular disorders

Secondary

MeasureTime frame
Due to auditory and vestibular impairment in people with fibromyalgia, quality of life is considerably affected;Auditory and vestibular alterations may be directly related to the disease itself;Participants who complained of auditory and vestibular symptoms stated that they had never had follow-up and treatment with the speech therapist and the otorhinolaryngologist

Countries

Brazil

Contacts

Public ContactDébora Fernandes

Centro Universitário Aparício Carvalho

heyfernandes@hotmail.com+55-069-984872353

Outcome results

None listed

Source: REBEC (via WHO ICTRP)